Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.50%
#3 Helium Helium +29.80%
#4 Pons Pons +28.26%
#5 TENDIES TENDIES +23.40%
#6 龙虾 (Lobster) 龙虾 (Lobster) +19.97%
#7 o1.exchange o1.exchange +18.32%
#8 Main Street Yield Main Street Yield +17.48%
#9 Nillion Nillion +16.96%
#10 Giggle Fund Giggle Fund +15.80%
Coin of the day
GEKKO GEKKO
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Paragon 28, Inc. Paragon 28, Inc.

Paragon 28, Inc.

FNA
Classement en actions #9071
Paragon 28, Inc. is a medical device company specializing in the development,... Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.
Prix de l'action
$13.09
Dernière synchronisation: 2025-04-17
Capitalisation boursière
$1.10B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Paragon 28, Inc. (FNA)

Catégorie

Healthcare
Ratio P/E pour Paragon 28, Inc. (FNA)
Ratio P/E au August 2026 TTM : -19.83
Selon les derniers rapports financiers et le cours de l'action de Paragon 28, Inc., le ratio P/E actuel (TTM) est de -19.83. À la fin de l’année 2023, le P/E de l’entreprise était de -17.73.
Historique du ratio P/E pour Paragon 28, Inc. de 2019 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
2026 (TTM) -19.83 25.93%
2024 -15.75 -11.19%
2023 -17.73 -18.61%
2022 -21.79 -77.94%
2021 -98.76 -118.56%
2020 532.01 109.94%
2019 253.41 0.00%
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -280.38%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -275.78%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -207.84%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -205.37%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.